Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 799 results for "continuous renal replacement therapy"

Developing the first treatment for Acute Kidney Injury. Spring 14
Drug Discovery World

1 images for "continuous renal replacement therapy"

IVTEAM, 2 months ago

Early mobilization on continuous renal replacement therapy is safe and may improve filter life

Research Yi Tian Wang , Terry P Haines , Paul Ritchie , Craig Walker , Teri A Ansell , Danielle T Ryan , Phaik-Sim Lim , Sanjiv Vij , Rebecca Acs , Nigel Fealy and Elizabeth H Skinner Critical Care 2014, 18 :R161 doi:10.1186/cc14001 ...
 Critical Care1 month ago Continuous Renal Replacement Therapy-Related Strategies to Avoid Colistin Toxicity: A Clinically Orientated Review  Sexual Development1 month ago

Preview: FDA September 17 Adcom On Testosterone Replacement Therapy

Summary The FDA is set to hold a joint meeting of the Bone, Reproductive and Urologic Drugs and the Drug Safety and Risk Management Advisory Committees on Sep. 17. The purpose of the meeting is to discuss the appropriate population for ...
 Seeking Alpha1 week ago

Amicus announces positive data from Phase III Fabry disease study

Amicus Therapeutics, Inc., a biopharmaceutical company, has announced positive 18-month data from its second Phase III study, or Study 012, with an oral small molecule chaperone, migalastat HCl, in Fabry patients with amenable mutations. Study 012 ...
 Individual.com3 weeks ago Amicus Therapeutics, Inc. Rockets On Positive Phase 3 Study Data For Rare Disease Drug; Stock Up +21.66% At 11:38AM ET On Wednesday  BioSpace1 month ago Amicus Therapeutics Announces Positive Phase 3 Data From Fabry Monotherapy Study 012  CEOWorld Magazine1 month ago AMICUS THERAPEUTICS : Announces Positive Phase 3 Data From Fabry Monotherapy Study 012  4 Traders1 month ago
[x]  

Amicus Therapeutics' (FOLD) CEO John Crowley on Phase III Fabry Monotherapy Study Results (Transcript)

Operator Good day, ladies and gentlemen, and welcome to the Amicus Phase 3 Fabry monotherapy results conference call. At this time all participants are in a listen only mode. Later we will conduct a question-and-answer session and instructions ...
 Seeking Alpha1 month ago Amicus' (FOLD) CEO John Crowley on Q2 2014 Results - Earnings Call Transcript  Seeking Alpha1 month ago

Merck Receives Accelerated Approval of KEYTRUDA® (pembrolizumab), the First FDA-Approved Anti-PD-1 Therapy

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab) at a dose of 2 mg/kg every three weeks for the treatment of patients with ...
 Pettinga Financial Advisors2 weeks ago (PR) Merck Receives Accelerated Approval of KEYTRUDA(R) (pembrolizumab), the First FDA-Approved Anti-PD-1 Therapy  Scottrade2 weeks ago MERCK : Receives Accelerated Approval of KEYTRUDA® (pembrolizumab), the First FDA-Approved Anti-PD-1 Therapy  4 Traders2 weeks ago
[x]  

Novartis' : investigational heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in PARADIGM-HF trial

LCZ696 mortality benefit exceeded what was achieved with enalapril, an ACE-inhibitor, when replacing enalapril combined with current treatment regimen for HF-REF 1 Study showed significantly more HF-REF patients on LCZ696 regimen were alive ...
 4 Traders3 weeks ago Novartis' investigational heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in PARADIGM-HF trial  Red Orbit3 weeks ago
[x]  
EuroInvestor

FDA Approves Genzyme Corporation's Gaucher Disease Pill Cerdelga

FDA Approves Genzyme's Cerdelga (eliglustat) Capsules First-Line Oral Therapy Approved for the Treatment of Adults with Gaucher Disease Type 1 CAMBRIDGE, Mass., Aug 19, 2014 (BUSINESS WIRE) -- Genzyme, a Sanofi company , announced today that ...
 BioSpace1 month ago 8/19/14 - FDA Approves Genzyme??s Cerdelga?¢ (eliglustat) Capsules  Pharmacy Choice1 month ago FDA Approves Genzyme's Cerdelga (eliglustat) Capsules  FierceBiotech1 month ago FDA Approves Genzyme's Cerdelga(TM) (eliglustat) Capsules  CNBC1 month ago
[x]  

Rockwell Medical, Inc. Reports Second Quarter 2014 Results

(GLOBE NEWSWIRE) -- . (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary ...
 Pettinga Financial Advisors1 month ago Rockwell Medical Schedules 2nd Quarter 2014 Investor Conference Call  Yahoo! Finance1 month ago Rockwell Medical Reports Second Quarter 2014 Results  BioSpace1 month ago Alexion Reports Second Quarter 2014 Results  CNBC1 month ago
[x]  

United Therapeutics Corporation Reports Second Quarter 2014 Financial Results

/PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the second quarter ended June 30, 2014. "Our continued growth shows that our medicines are reaching increasing numbers of patients suffering ...
 TickerTech.com1 month ago Second Quarter & Half Year Results 2014  TrustNet1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less